LPL variant therapeutics

• 收藏
• 分享

专利权人:

Michael R. Hayden

发明人:

Michael R. Hayden,John P. Kastelein

申请号：

US14324151

公开号：

US09290751B2

申请日:

2014.07.04

申请国别(地区):

US

年份:

2016

代理人:

摘要：

The invention provides for the use of a therapeutic derived from a truncated lipoprotein lipase protein (LPL S447X), including nucleic acids encoding such proteins, for the treatment of conditions including LPL responsive conditions, such as cardiovascular disease, hypertension, LPL deficiency, high triglyceride levels, low HDL-cholesterol levels or atherosclerosis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/